Gamete Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 13-12-2024
- Revenue 9.87%
(FY 2017)
- Profit 89.99%
(FY 2017)
- Ebitda 4.46%
(FY 2017)
- Net Worth 15.02%
(FY 2017)
- Total Assets 30.89%
(FY 2017)
About Gamete Pharma
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Sushama Singh and Jitendra Singh serve as directors at the Company.
- CIN/LLPIN
U24232UP2006PTC032172
- Company No.
032172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationVaranasi-221005, Uttar Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gamete Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushama Singh  | Director | 24-Apr-2015 | Current |
| Jitendra Singh | Director | 21-Jul-2006 | Current |
Financial Performance of Gamete Pharma.
Gamete Pharma Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 9.87% increase. The company also saw a substantial improvement in profitability, with a 89.99% increase in profit. The company's net worth Soared by an impressive increase of 15.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gamete Pharma?
In 2017, Gamete Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 21 Aug 2017 | ₹2.00 M | Open |
How Many Employees Work at Gamete Pharma?
Unlock and access historical data on people associated with Gamete Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gamete Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gamete Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
